Effective in Europe from February 2019, EU directive 2011/62/EU, also referred to as EU FMD, aims to reduce counterfeiting of prescription drugs by tracking and tracing the passage of drugs through the entire supply chain.
Under the Directive, all new packs of prescription medicines placed on the market in Europe from February 2019 onwards will have to bear two safety features: a verifiable unique identifier (serialised code) and an anti-tamper device.
With one year to go for pharmaceutical manufacturers, packaging sites and Marketing Authorisation Holders (MAHs) to achieve compliance with the Falsified Medicines Directive, watch the video below to learn about what is required and what your solution from Antares Vision and Crest Solutions could look like.
Here's a month-by-month break down on how to comply and optimise your pharmaceutical packaging lines before 09 February 2019.
One Year for EU FMD Implementation: A month-by-month guide to compliance
With one year to go for pharmaceutical manufacturers, packaging sites and Marketing Authorisation Holders (MAHs) to achieve compliance with the Falsified Medicines Directive, the team in Crest Solutions have put together this guide to help you meet the deadline.
The Excellence Through People scheme guides many of Ireland’s most successful organisations to become more efficient, productive, flexible, competitive and innovative, through the development of great people.
We are delighted to announce that Crest Solutions has won the top prize of €40,000 in IrishJobs.ie’s ‘Payback' Competition.
The competition asked entrants to outline how a recent hire through IrishJobs.ie had helped to improve and grow their business.
Frank Madden is the founder and CEO of Crest Solutions, a leading provider of automated vision inspection and anti-counterfeiting solutions for the pharmaceutical packaging industry that currently employs 87 people in Ireland.
Tackling counterfeit medicine
In 2013, Antares Vision, Crest Solutions and our sister company VistaLink joined forces as key partners.
Our objective was to deliver the leading range of Antares Vision serialisation solutions to pharmaceutical sites in Ireland, the UK, Benelux and Scandinavia, assisting to tackle the global issue of counterfeit medicines.
We are delighted to present Lifesciences Trends 2017: A National and Regional Perspective. Join us at the Radisson Blu Hotel & Spa, Ditchley House, Cork on November 15th, as we explore the topics that have shaped and impacted the Lifesciences sector in Ireland and in particular, the Munster region.
Download the Lifesciences Trends 2017 Conference Brochure.
Following the hugely successful Serialisation Forum run by PCI and Partners in January 2017, we are back this November to share our experiences in achieving compliance on projects throughout the year.
Assisting a highly skilled workforce to rejoin the world of work.
Crest Solutions is proud to support ReBOOT, an initiative which has been launched in order to assist women who wish to rejoin the world of work following time pursuing other goals.
"A number of Ireland's top technology firms are backing the Women ReBOOT initiative, the first time such a collaboration has occurred, in response to the gender imbalance in IT.